Isobromindione

This classification denotes a uricosuric agent with the molecular formula C15H9BrO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J1J87P409K, chemically known as 1,3-indandione, 5-bromo-2-phenyl- but generally known as isobromindione, which bears US NIH Compound Identifier 68953. European Medicines Agency schedules Isobromindione in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08311MIG. The term ISOBROMINDIONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, No. 5, 1985, List 25). World Health Organization schedules isobromindione in its Anatomical Therapeutic Chemical (ATC) Classification. ISOBROMINDIONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule isobromindione under HS 29147000 and SITC 51629. As of Q4 2014, ISOBROMINDIONE remains the US FDA Preferred Term for this commodity. Isobromindione bears US NLM identifiers UMLS ID C1881274 and NCI Concept Code C65971. SMILES: BRC1CC2C(C(=O)C(C2=O)C2CCCCC2)CC1.